Streetbeat News

Revenues

AA

JPMorgan's Commodities Research team predicts near-term consolidation in aluminum prices due to a surplus in China's market, but expects a long-term rebound driven by global supply constraints and increased demand. Alcoa (NYSE:AA) is strategically positioned to benefit from these dynamics, particularly due to its exposure to alumina and potential sale of its loss-making San Ciprian complex.

Portfolio Pulse from Surbhi Jain

June 03, 2024 | 7:30 pm

FRT

Federal Realty Investment Trust has acquired the Virginia Gateway Retail Center for $215 million. This acquisition is expected to enhance FRT's portfolio and potentially increase its revenue streams.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 7:12 pm

KMB

Analysts have provided a range of evaluations for Kimberly-Clark (NYSE:KMB) over the past three months, with a mix of bullish, bearish, and neutral ratings. The average 12-month price target has increased to $137.18, reflecting a 6.96% rise from the previous target. Analysts have raised their price targets, indicating a positive outlook despite recent revenue challenges.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 7:01 pm

PACB

Pacific Biosciences (NASDAQ:PACB) has received a range of analyst ratings over the past three months, with a notable decline in the average 12-month price target from $8.00 to $3.64. Analysts have predominantly lowered their ratings and price targets, reflecting a bearish sentiment. The company's financial metrics, including a decline in revenue and high debt-to-equity ratio, indicate potential challenges ahead.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 7:00 pm

WING

Wingstop (NASDAQ:WING) has significantly outperformed the market over the past 5 years, delivering an average annual return of 32.42%. A $1000 investment in WING 5 years ago would be worth $4,137.74 today. The article highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 7:00 pm

NVO

Novo Nordisk (NYSE:NVO) has significantly outperformed the market over the past 10 years, delivering an average annual return of 19.79%. A $100 investment in NVO 10 years ago would now be worth $626.97. The article highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 6:30 pm

PSTG

Pure Storage (NYSE:PSTG) has significantly outperformed the market over the past 5 years, delivering an average annual return of 30.72%. A $100 investment in PSTG 5 years ago would now be worth $381.19. The company's current market capitalization is $19.23 billion.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 6:30 pm

AFMD

Affimed N.V. (NASDAQ: AFMD) shares surged on Monday following the release of promising clinical data from its AFM24-102 study in non-small cell lung cancer (NSCLC). The data showed significant clinical efficacy and a manageable safety profile for the combination of AFM24 and atezolizumab, leading to an 81.4% increase in AFMD's stock price.

Portfolio Pulse from Vandana Singh

June 03, 2024 | 6:13 pm

S

Over the past three months, 22 analysts have evaluated SentinelOne (NYSE:S), showing a range of sentiments from bullish to bearish. The average 12-month price target is $27.77, down 4.6% from the previous average. Analysts have mostly lowered their price targets, reflecting a cautious outlook. SentinelOne has shown strong revenue growth but faces challenges in profitability and financial performance.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 6:01 pm

TXG

Analysts have provided mixed ratings for 10x Genomics (NASDAQ:TXG) over the past three months, with a notable decline in the average 12-month price target. The company's financial metrics show positive revenue growth but challenges in profitability and returns.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 6:01 pm